nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—Angina unstable—Riluzole—amyotrophic lateral sclerosis	0.0831	0.114	CcSEcCtD
Argatroban—F2—forelimb—amyotrophic lateral sclerosis	0.0735	0.31	CbGeAlD
Argatroban—F2—hindlimb—amyotrophic lateral sclerosis	0.0662	0.279	CbGeAlD
Argatroban—Disseminated intravascular coagulation—Riluzole—amyotrophic lateral sclerosis	0.0588	0.0804	CcSEcCtD
Argatroban—F2—appendage—amyotrophic lateral sclerosis	0.0568	0.239	CbGeAlD
Argatroban—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.0302	0.0413	CcSEcCtD
Argatroban—Thrombosis—Riluzole—amyotrophic lateral sclerosis	0.0296	0.0406	CcSEcCtD
Argatroban—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.0284	0.0388	CcSEcCtD
Argatroban—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.0274	0.0375	CcSEcCtD
Argatroban—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0261	0.0357	CcSEcCtD
Argatroban—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.0248	0.0339	CcSEcCtD
Argatroban—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.0214	0.0292	CcSEcCtD
Argatroban—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.021	0.0287	CcSEcCtD
Argatroban—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.021	0.0287	CcSEcCtD
Argatroban—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.0187	0.0255	CcSEcCtD
Argatroban—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.0182	0.0249	CcSEcCtD
Argatroban—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0161	0.022	CcSEcCtD
Argatroban—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0214	CcSEcCtD
Argatroban—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0152	0.0208	CcSEcCtD
Argatroban—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0198	CcSEcCtD
Argatroban—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0175	CcSEcCtD
Argatroban—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0162	CcSEcCtD
Argatroban—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0158	CcSEcCtD
Argatroban—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0157	CcSEcCtD
Argatroban—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0156	CcSEcCtD
Argatroban—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0153	CcSEcCtD
Argatroban—F2—spinal cord—amyotrophic lateral sclerosis	0.0107	0.0453	CbGeAlD
Argatroban—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0147	CcSEcCtD
Argatroban—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0145	CcSEcCtD
Argatroban—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0144	CcSEcCtD
Argatroban—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00956	0.0131	CcSEcCtD
Argatroban—F2—nervous system—amyotrophic lateral sclerosis	0.00905	0.0381	CbGeAlD
Argatroban—F2—Regulation of IGF Activity by IGFBP—IGFALS—amyotrophic lateral sclerosis	0.00896	0.283	CbGpPWpGaD
Argatroban—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00887	0.0121	CcSEcCtD
Argatroban—F2—central nervous system—amyotrophic lateral sclerosis	0.00871	0.0367	CbGeAlD
Argatroban—Cough—Riluzole—amyotrophic lateral sclerosis	0.008	0.0109	CcSEcCtD
Argatroban—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00781	0.0107	CcSEcCtD
Argatroban—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00755	0.0103	CcSEcCtD
Argatroban—Infection—Riluzole—amyotrophic lateral sclerosis	0.00744	0.0102	CcSEcCtD
Argatroban—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00731	0.01	CcSEcCtD
Argatroban—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.007	0.00957	CcSEcCtD
Argatroban—F2—brain—amyotrophic lateral sclerosis	0.00692	0.0292	CbGeAlD
Argatroban—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00667	0.00913	CcSEcCtD
Argatroban—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00659	0.00901	CcSEcCtD
Argatroban—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00646	0.00884	CcSEcCtD
Argatroban—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0064	0.00876	CcSEcCtD
Argatroban—Pain—Riluzole—amyotrophic lateral sclerosis	0.0064	0.00876	CcSEcCtD
Argatroban—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00617	0.00844	CcSEcCtD
Argatroban—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00612	0.00837	CcSEcCtD
Argatroban—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00592	0.0081	CcSEcCtD
Argatroban—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00592	0.0081	CcSEcCtD
Argatroban—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00552	0.00755	CcSEcCtD
Argatroban—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00512	0.00701	CcSEcCtD
Argatroban—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00495	0.00677	CcSEcCtD
Argatroban—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00476	0.00651	CcSEcCtD
Argatroban—Rash—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00646	CcSEcCtD
Argatroban—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00645	CcSEcCtD
Argatroban—Headache—Riluzole—amyotrophic lateral sclerosis	0.00469	0.00642	CcSEcCtD
Argatroban—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00445	0.00608	CcSEcCtD
Argatroban—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00275	0.0116	CbGeAlD
Argatroban—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00265	0.0112	CbGeAlD
Argatroban—F2—Regulation of IGF Activity by IGFBP—IGFBP3—amyotrophic lateral sclerosis	0.00224	0.0708	CbGpPWpGaD
Argatroban—F2—Complement and Coagulation Cascades—C5AR1—amyotrophic lateral sclerosis	0.00123	0.039	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.00109	0.0345	CbGpPWpGaD
Argatroban—F2—Regulation of IGF Activity by IGFBP—IGF1—amyotrophic lateral sclerosis	0.000947	0.0299	CbGpPWpGaD
Argatroban—F2—Post-translational protein modification—PIGW—amyotrophic lateral sclerosis	0.000883	0.0279	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.000764	0.0241	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PFN1—amyotrophic lateral sclerosis	0.00067	0.0212	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000621	0.0196	CbGpPWpGaD
Argatroban—F2—IL1 and megakaryotyces in obesity—MMP9—amyotrophic lateral sclerosis	0.000619	0.0195	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000564	0.0178	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.000553	0.0175	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000543	0.0171	CbGpPWpGaD
Argatroban—F2—Complement and Coagulation Cascades—C3—amyotrophic lateral sclerosis	0.000539	0.017	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00052	0.0164	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000494	0.0156	CbGpPWpGaD
Argatroban—F2—Syndecan-4-mediated signaling events—MMP9—amyotrophic lateral sclerosis	0.000492	0.0155	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000489	0.0154	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.000484	0.0153	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.000419	0.0132	CbGpPWpGaD
Argatroban—F2—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000404	0.0127	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.000383	0.0121	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000325	0.0103	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000318	0.01	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00029	0.00916	CbGpPWpGaD
Argatroban—F2—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00028	0.00884	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000262	0.00826	CbGpPWpGaD
Argatroban—F2—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00026	0.00821	CbGpPWpGaD
Argatroban—F2—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000252	0.00796	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.00025	0.00788	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000247	0.00781	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000236	0.00746	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.00022	0.00695	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000212	0.00669	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.000211	0.00667	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000187	0.00591	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000187	0.0059	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000144	0.00455	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000142	0.00448	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00014	0.00441	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000138	0.00436	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000135	0.00426	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00013	0.0041	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000128	0.00404	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000127	0.00401	CbGpPWpGaD
Argatroban—F2—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000122	0.00385	CbGpPWpGaD
Argatroban—F2—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000109	0.00345	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000108	0.00341	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	9.95e-05	0.00314	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	9.95e-05	0.00314	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	9.9e-05	0.00312	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	9.41e-05	0.00297	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	9.3e-05	0.00294	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	9.1e-05	0.00287	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	8.82e-05	0.00278	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.54e-05	0.0027	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.46e-05	0.00267	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	7.96e-05	0.00251	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.59e-05	0.00239	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.5e-05	0.00237	CbGpPWpGaD
Argatroban—F2—Hemostasis—IGF1—amyotrophic lateral sclerosis	7.43e-05	0.00235	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	7.2e-05	0.00227	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.27e-05	0.00198	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.1e-05	0.00193	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.04e-05	0.00191	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.96e-05	0.00188	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	5.84e-05	0.00184	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.54e-05	0.00175	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	5.45e-05	0.00172	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.15e-05	0.00163	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	5.03e-05	0.00159	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	4.85e-05	0.00153	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.83e-05	0.00153	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	4.63e-05	0.00146	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	4.63e-05	0.00146	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.6e-05	0.00145	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	4.23e-05	0.00134	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	4.13e-05	0.0013	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.94e-05	0.00124	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.93e-05	0.00124	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.7e-05	0.00117	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	3.7e-05	0.00117	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—amyotrophic lateral sclerosis	3.67e-05	0.00116	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	3.35e-05	0.00106	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.27e-05	0.00103	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.05e-05	0.000962	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.54e-05	0.0008	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.52e-05	0.000795	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.34e-05	0.000739	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.22e-05	0.000701	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.04e-05	0.000644	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.94e-05	0.000612	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.92e-05	0.000607	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.83e-05	0.000578	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	1.68e-05	0.00053	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.64e-05	0.000519	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.24e-05	0.000392	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.15e-05	0.000363	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.03e-05	0.000326	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.49e-06	0.0003	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	7.81e-06	0.000246	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.35e-06	0.000169	CbGpPWpGaD
